FDA Expert Witness Services

Leverage The Most Trusted FDA Experts in the World

When litigation hinges on FDA compliance and regulatory interpretation, credibility and clarity are everything. ProPharma's expert witness consulting services deliver unparalleled insight, strategic support, and courtroom-ready testimony from the largest team of former FDA and senior industry professionals in the world. Whether you're involved in a business dispute, product liability case, patent issue, or pursuing damages in a regulatory dispute, we provide expert guidance rooted in real-world FDA experience and scientific rigor.

Comprehensive FDA Expertise Across Product Areas

We support legal teams and life sciences clients in a wide range of matters involving FDA-regulated products, including:

  • FDA Enforcement Actions: 483 observations, warning letters, consent decrees, import detentions, and recalls
  • Product Development & Approval Pathways: NDAs, ANDAs, 510(k)s, PMAs, De Novo submissions, and combination product strategies
  • Pharmaceutical, Biotech & Device Litigation: Adulteration, misbranding, product liability, and regulatory negligence claims
  • Advertising & Promotional Compliance: OPDP compliance, off-label promotion, fair balance, and substantiation disputes
  • Clinical Trials & GCP Compliance: Site inspections, data integrity, informed consent violations, protocol deviations
  • Manufacturing & Quality Systems: cGMP/QSR deficiencies, supplier quality, CAPAs, MDRs, and risk management gaps

Our team of FDA Expert Witness Consultants brings an insider’s perspective to every case—identifying gaps, explaining regulatory expectations, and anticipating FDA interpretations that can sway outcomes.

Why Choose ProPharma's Team of FDA Expert Witness Consultants?

Our expert team sets the global standard for FDA-related litigation support. We offer:

Unmatched Regulatory Expertise

Our roster is comprised of more former FDA employees than any other consulting firm—including former reviewers, inspectors, compliance officers, and division directors who understand FDA expectations from the inside out. Our bench also consists of many senior industry executives, with an impressive breadth and depth of scientific and regulatory expertise.

Scientific and Strategic Depth

In addition to regulatory backgrounds, our experts are PhD/MD scientists, clinical trialists, engineers, and manufacturing specialists with deep domain knowledge across the product lifecycle.

Credible, Court Tested Authority

We are the most trusted FDA expert witnesses in the world, with extensive experience supporting clients in federal and state courts, arbitration panels, and regulatory hearings.

Clarity That Persuades

Our consultants translate complex regulatory and scientific concepts into clear, defensible testimony that resonates with judges, juries, and legal counsel alike.

Strategic Support at Every Stage of Litigation

Whether you're building your case or preparing for trial, we serve as a strategic partner throughout the legal process:

  • Early Case Assessment: We help legal teams evaluate regulatory strengths and weaknesses and refine case strategy
  • Expert Reports & Declarations: Our experts craft detailed, objective reports that withstand scrutiny and communicate clearly
  • Deposition & Trial Testimony: Our seasoned experts are skilled at delivering confident, credible testimony that holds up under cross-examination
  • Rebuttal & Opposing Expert Analysis: We review and critique the opinions and assumptions of opposing FDA experts to help you anticipate challenges and build counterpoints

From technical assessments to high-stakes testimony, ProPharma’s expert witness consultants deliver the insight and authority your case needs.

biotech-startup-team-being-shown-a-presentation

Who We Serve

Casually worker business professionals collaborating at a conference table

Our FDA expert witness services are trusted by top-tier clients around the world, including:

  • Law Firms representing pharmaceutical, medical device, biotechnology, and diagnostics companies in civil, criminal, and regulatory matters
  • Life Sciences Companies facing litigation, government investigations, product recalls, or shareholder actions
  • Insurance Providers & Risk Managers seeking defensible analysis of regulatory compliance and product safety claims
  • Litigation Support Firms in need of high-caliber expert evaluation, documentation review, and testimony

When regulatory credibility is on the line, leading firms rely on our unparalleled FDA knowledge and litigation support capabilities.

Partner with the World's Leading FDA Experts

With the largest team of former FDA professionals and globally recognized scientific and regulatory expertise, we are the trusted authority for FDA expert witness support. Our consultants have shaped policy, led inspections, reviewed product submissions, and now help clients succeed in high-stakes litigation.

ProPharma: The World's Leading Regulatory Consultancy

Contact us today to discuss your case and learn how our experts can strengthen your legal strategy with insight that only firsthand FDA experience can provide.

News & Insights

Good Machine Learning Practice (GMLP)

November 17, 2025

Good Machine Learning Practice (GMLP)

Ensuring AI/ML in life sciences meets regulatory standards with ProPharma's GMLP framework, blending innovation with compliance for reliable, safe, and effective digital transformation.

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

Good Machine Learning Practice (GMLP)

November 17, 2025

Good Machine Learning Practice (GMLP)

Ensuring AI/ML in life sciences meets regulatory standards with ProPharma's GMLP framework, blending innovation with compliance for reliable, safe, and effective digital transformation.

Influencers in Pharma: A Growing Compliance Frontier

November 11, 2025

Influencers in Pharma: A Growing Compliance Frontier

Ensure FDA-compliant pharma influencer campaigns with insights on OPDP rules, risk disclosure, platform challenges, and sponsor oversight responsibilities.

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local Infrastructure

November 6, 2025

Reclaiming the European Market: How to Secure EU/UK MAH Status Without the Local...

Discover how non-European pharma companies can quickly and compliantly secure EU/UK Marketing Authorisation Holder status without local infrastructure, ensuring market success.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Article The Relevance of AI in Medical Information: Transforming Communication, Compliance, and Care - ProPharma

November 5, 2025

The Relevance of AI in Medical Information: Transforming Communication, Complian...

Artificial intelligence (AI) is no longer a future concept — it’s transforming Medical Information (MI) today. In a field where accuracy, empathy, and speed define trust, AI is emerging not just as a...

Article Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy - ProPharma

October 30, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Inform...

In today’s data-driven pharmaceutical landscape, patient safety depends on more than vigilance — it demands collaboration. Pharmacovigilance and Medical Information teams are no longer operating in...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow